# Comparative Trial Between Ainuovirine(ANV)/Lamivudine(3TC)/Tenofovir(TDF) and Efavirenz(EFV)/Lamivudine/Tenofovir Regimens

> **NCT07631897** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Shanghai Public Health Clinical Center** · enrollment: 60 (estimated)

## Conditions studied

- HIV
- Art Therapy
- TB - Tuberculosis

## Interventions

- **DRUG:** Ainuovirine, Lamivudine and Tenofovir Disoproxil Fumarate Tablets
- **DRUG:** Tenofovir, Lamivudine and Efavirenz Disoproxil Fumarate Tablets

## Key facts

- **NCT ID:** NCT07631897
- **Lead sponsor:** Shanghai Public Health Clinical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06
- **Primary completion:** 2028-06
- **Final completion:** 2028-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07631897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07631897, "Comparative Trial Between Ainuovirine(ANV)/Lamivudine(3TC)/Tenofovir(TDF) and Efavirenz(EFV)/Lamivudine/Tenofovir Regimens". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07631897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*